Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial

PABLO PEREZ MARTINEZFRANCISCO JAVIER DELGADO LISTARAUL MIGUEL LUQUE HUERTAS2026-01-292026-01-29202410.1186/s12933-024-02175-52-s2.0-85187944697https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37574Cardiology and Cardiovascular MedicineEndocrinology, Diabetes and MetabolismInternal MedicineTelomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trialresearch article